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Summary 
The determination of lactate dynamics in brain tissue represents a challenge, partly because in vivo 
data at cellular resolution are not available. Here we monitored lactate in astrocytes and neurons of 
the primary somatosensory cortex of mice using the genetically-encoded FRET sensor Laconic in 
combination with two-photon laser scanning microscopy. An intravenous lactate injection rapidly 
increased the Laconic signal in both astrocytes and neurons, demonstrating high lactate permeability 
across the tissue. The signal increase was significantly smaller in astrocytes pointing to higher basal 
lactate levels in these cells, confirmed by a one-point in vivo calibration protocol.  
Trans-acceleration of the monocarboxylate transporter with pyruvate was able to reduce intracellular 
lactate in astrocytes but not in neurons. Collectively, this data provides in vivo evidence for a lactate 
gradient from astrocytes to neurons.  
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Introduction 
The energy demand of mammalian brain tissue is met mainly by degradation of blood borne glucose. 
Classical experiments with radiolabeled substrates showed label incorporation into glutamate and 
glutamine in a manner suggestive of two separate tricarboxylic acid cycles, a ‘large’ and a ‘small’ 
compartment (Van den Berg et al., 1969), which were assigned to neurons and astrocytes respectively 
using immunohistochemical techniques (Martinez-Hernandez et al., 1977). The concept of 
compartmentation in brain energy metabolism gained new momentum with the postulation of the 
astrocyte neuron lactate shuttle model (ANLS). In the classical version of this hypothesis, glutamate 
transients are linked to a cellular compartmentation of lactate (Pellerin and Magistretti, 1994). 
Glutamate released from active neurons activates astrocytic glycolysis leading to production of lactate, 
which serves as an energy source for neurons. Increased brain lactate levels upon neuronal activation 
have been observed in several studies via different techniques (Hu and Wilson, 1997; Lin et al., 2010; 
Prichard et al., 1991; Sappey-Marinier et al., 1992). Also, L-lactate acts as a signaling molecule in certain 
mammalian brain regions (Mosienko et al., 2015; Tang et al., 2014; Yang et al., 2014). However, the 
cellular origin of lactate released during increased activity (Barros and Deitmer, 2010; Stobart and 
Anderson, 2013) and its significance as an energy substrate or signaling molecule remains largely 
unclear (Barros, 2013; Weber and Barros, 2015).  
Experimental evidence from in vitro and in vivo animal studies demonstrate that lactate is able to 
sustain neuronal activity during glucose deprivation (Schurr, 2002; Wyss et al., 2011) and patients with 
non-penetrating traumatic brain injuries use peripheral lactate as brain energy substrates (for review 
see Glenn et al., 2015). Furthermore, lactate transport across cell membranes via monocarboxylate 
transporters (MCTs) is a facilitated transport (Halestrap and Wilson, 2012). Increased lactate 
production in one cell type and predominant lactate consumption in another cell type would therefore 
require a lactate concentration gradient from the ‘producer’ to the ‘consumer’. Lactate dehydrogenase 
(LDH), located in mitochondria and the surrounding cytoplasm (Brooks et al., 1999), links lactate to 
oxidative metabolism, by catalyzing the conversion between lactate and pyruvate.  The higher affinity 
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for lactate of MCT and LDH isoforms expressed in neurons (MCT2 and LDH1) relative to the isoforms 
expressed in astrocytes (MCT1/4 and LDH5) supports an astrocytic production and neuronal 
consumption of lactate (Bittar et al., 1996; Debernardi et al., 2003; Laughton et al., 2000; Pierre and 
Pellerin, 2005). Inhibition of astrocytic production and neuronal consumption of lactate via LDH 
inhibition reduces epileptic neuronal activity, possibly due to neuronal ATP depletion (Sada et al., 
2015). Moreover, the fast and transient lactate depletion in astrocytes during different in vivo and in 
vitro stimulation paradigms may represent the emptying of a lactate pool (Sotelo-Hitschfeld et al., 
2015). Taken together, these results suggest a lactate concentration gradient from astrocytes to 
neurons; however, in vivo evidence of such a cellular gradient is currently absent.  
Here, we investigated cell-specific lactate reservoirs in vivo employing the recently developed 
genetically encoded biosensor Laconic (San Martín et al., 2013), which we specifically expressed in 
astrocytes and neurons. Through two-photon laser scanning microscopy (2PLSM; Denk et al., 1990), 
we show, for the first time, direct indication of an in vivo lactate gradient from astrocytes to neurons. 
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Results 
Expression of Laconic and Pyronic in vivo 
To evaluate the specificity of Laconic transients, a biosensor construct specific for pyruvate (‘Pyronic’; 
San Martín et al., 2014) was measured simultaneously with Laconic. Different adeno-associated viral 
(AAV) vectors, encoding either the Laconic or the Pyronic sensors, were injected in close distance to 
each other at the center of a craniotomy in the primary somatosensory cortex of mice (Figure 1A, S1A). 
The fluorescence of both sensors, driven by the short GFAP promoter, was located in the cytoplasm 
and showed the typical morphology of protoplasmic cortical astrocytes, including vascular end-feet 
and fine processes outlining dark non-fluorescent cells (Figure 1B). A similar fluorescence pattern was 
found throughout all imaged cortical layers, consistent with non-overlapping astrocytic domains in 
mice (Oberheim et al., 2009). Human synapsin promoter constructs induced cytoplasmic fluorescence 
in cells matching neuronal morphology, with dark nuclei and long ranging processes toward superficial 
or deeper structures, located more than 150 µm below the dura (Figure 1B). 2PLSM was restricted to 
layer 2/3 cells with a laser power above 20 mW to ensure stable FRET ratios (Figure S1F) and below 40 
mW to prevent tissue damage and bleaching of the fluorescence. Immunohistochemical staining for 
GFAP, CD68 and fibrinogen revealed no increase in gliosis, microglial activity or blood-brain barrier 
leakage (Figures S1A-D).  
Insert Figure 1 about here. 
 
Laconic sensor functions are comparable in vivo and in vitro 
L-lactate binding induces a conformational change of Laconic causing a decrease in fluorescent 
resonance energy transfer (FRET) efficiency which increases the ratio of mTFP (monomeric teal 
fluorescent protein) over Venus (Figure 1A). In vitro lactate application leads to two-site saturable 
Laconic kinetics without pH sensitivity (Figure 1C and S1F, San Martín et al., 2013). The functionality of 
the sensor in vivo was demonstrated with increasing doses of sodium-L-lactate injected via a tail vein 
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catheter during 2PLSM. Laconic signals in neurons and astrocytes increased non-linearly with the 
intravenously injected lactate dose but did not respond to 500 mM saline injections (Figure 2A, S1E). 
The amplitudes of Laconic signal changes in vivo were of the same order of magnitude as in vitro cell 
culture, where Laconic signals can be explored at a much wider range of lactate concentrations (Figure 
2B). 
Insert Figure 2 about here. 
 
A single intravenous injection of lactate increases Laconic signal more in neurons than in astrocytes 
To compare lactate accumulation in astrocytes and neurons, Laconic was simultaneously measured in 
neurons and astrocytes during short intravenous L-lactate infusions over three minutes (4 mmol/kg 
bodyweight), elevating blood lactate levels from 0.81 ± 0.26 mM to 17 ± 5.7 mM (Figure 3C). The 
Laconic signal increased more significantly in neurons than in astrocytes (5.7 ± 1.3% vs. 4.3 ± 1.3%, 
respectively; Figure 3A) with a rise in extracellular lactate levels of 0.27 ± 0.08 mM (Figure 3B). This 
discrepancy between neurons and astrocytes could reflect higher lactate accumulation in neurons at 
similar baseline lactate concentrations in both cell types. Alternatively, this difference could be 
attributed to lower baseline lactate concentrations in neurons, which would permit a greater upward 
dynamic range and sensitivity of Laconic.  Insert Figure 3 about here. 
To distinguish between these two possibilities, the baseline lactate concentrations in astrocytes and 
neurons were compared by saturating Laconic in both cellular compartments. Ammonium chloride 
infusion over four minutes (2.5 mmol/kg bodyweight), which boosts cytosolic lactate concentration in 
brain cells by inhibiting mitochondrial pyruvate consumption (Lerchundi et al., 2015), increased 
Laconic signals in neurons and astrocytes (7.3 ± 1.3% vs. 7.4 ± 1.6%, respectively; Figure S1H). When 
ammonium chloride and L-lactate were simultaneously infused intravenously beforehand, additional 
L-lactate application induced a significantly smaller increase of the Laconic signal in neurons (0.95 ± 
0.62%, n = 53,  p < 0.05, one-sample t-test) and astrocytes (0.57 ± 0.55%, n = 43 cells, p < 0.05, one-
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sample t-test) (Figure 4A) compared to the same lactate infusion in Figure 3 (p < 10-7, two-sample t-
test). However, extracellular lactate levels continued to increase with additional lactate infusion by 16 
± 10.7% of the total increase (p < 0.05, one-sample t-test) (Figure 4B). This suggests that ammonium 
chloride administration increased intracellular lactate concentrations to levels which saturated 
Laconic. Overall, a greater change in neuronal Laconic signal was observed (∆FRET signal: 9.9 ± 2.4 %) 
compared to astrocytes (6.9 ± 2.0 %), supporting our hypothesis of lower baseline lactate levels in 
neurons (Figure 4A).  
Insert Figure 4 about here. 
Pronounced trans-acceleration in astrocytes occurs at baseline 
Pyruvate application has been used in vitro to decrease intracellular lactate levels in erythrocytes 
(Fishbein et al., 1988). This effect is based on a property of MCTs called trans-acceleration (Figure 5E), 
where the presence of extracellular monocarboxylates stimulates transporter substrate efflux. This 
process involves a facilitated conformational switch of the substrate binding site across the cell 
membrane when an adequate substrate is bound (Figure S2G, Garcia et al., 1994; Halestrap, 2013).  
To test the capacity of intravenously applied pyruvate to produce a trans-acceleration-induced lactate 
efflux out of brain cells, extracellular brain lactate levels were measured with Pinnacle© biosensors 
(Figure S3D). Intravenous injection of 4 mmol/kg pyruvate over three minutes induced a transient 
increase of extracellular lactate levels of 0.084 ± 0.022 mM (Figure 5B), consistent with trans-
acceleration of MCTs.  
To compare trans-acceleration of MCTs in neurons and astrocytes, simultaneous measurements of 
Laconic and Pyronic during pyruvate application were performed. At baseline lactate levels, pyruvate 
decreased Laconic signal in astrocytes (-4.7 ± 1.5%), while signal in neurons was relatively unchanged 
(-0.6 ± 0.9%; Figure 5A). Pyronic showed only minor changes. However, after achieving higher 
intracellular lactate concentrations by the combined infusion of ammonium chloride and lactate, 
pyruvate administration was able to decrease Laconic signals in both astrocytes and neurons while 
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increasing Pyronic signals in both cells (Figure 5C). Upon repeated i.v. injections of pyruvate, neuronal 
Laconic signal kept increasing, possibly due to the conversion of pyruvate to lactate (Gonzalez et al., 
2005). Under these high lactate conditions, both astrocytes and neurons show trans-acceleration 
(Figure 5D), demonstrating that neuronal MCTs are also susceptible to pyruvate-driven efflux (Figure 
5E). In a subset of recordings this lactate accumulation was absent in neurons, in which case a lactate 
depletion during pyruvate infusions could not be observed. 
Insert Figure 5 about here. 
 
Discussion 
The compartmentation of brain energy metabolism is a subject of intense debate, fuelled by a lack of 
accurate in vivo intracellular lactate measurements in different cell populations. Here, we utilized the 
genetically encoded lactate sensor Laconic to observe the capacity of blood borne lactate to enter both 
astrocytes and neurons and to approximate lactate concentrations in these cells. Whole brain tissue 
uptake of lactate from blood has previously been demonstrated in vivo (Cremer et al., 1979; Klein and 
Olsen, 1947; Wyss et al., 2011) and has been quantified in humans (Glenn et al., 2015; van Hall et al., 
2009). We observed an accumulation of cellular and extracellular brain lactate during artificially 
increased blood lactate levels, which indicate a net uptake under these conditions and is in agreement 
with findings in humans (Boumezbeur et al., 2010; Quistorff et al., 2008; Rasmussen et al., 2011). The 
ability of neurons to take up lactate is an important prerequisite for the use of lactate as an energy 
substrate as suggested by the ANLS (Bélanger et al., 2011; Magistretti and Allaman, 2015), a concept 
that is still debated (Dienel, 2012 and references therein). Lactate has been shown to enter oxidative 
energy production in physiological resting conditions (Bouzier-Sore et al., 2006) and support neuronal 
activity under low-glucose conditions both in vitro (Tekkök et al., 2005) and in vivo (Herzog et al., 2013; 
Wyss et al., 2011). 
9 
 
We observed a greater neocortical Laconic signal increase in neurons than in astrocytes when blood 
lactate was elevated. This cell type difference was not due to altered Laconic sensitivity, as cumulative 
signal amplitudes were similar in both populations after decreasing intracellular lactate with pyruvate 
infusions and normalizing to the saturated sensor (Figure S1I). Therefore, baseline neuronal lactate 
levels could be lower where Laconic is more responsive. To evaluate this possibility, Laconic was 
saturated in both cellular compartments simultaneously using a mixture of lactate and ammonium 
(Provent et al., 2007), which revealed a higher maximal increase of neuronal Laconic and suggests a 
lower baseline lactate concentration in neurons than in astrocytes (Figure 6A). 
We utilized the trans-acceleration property of MCTs (Brown and Brooks, 1994) by applying an inward 
pyruvate gradient to force the cells to release their lactate. The pronounced drop of astrocytic lactate 
and the negligible decrease in neurons is in agreement with higher resting lactate levels in astrocytes 
(Figure 6B). We can reject the following alternative explanations for the astrocyte-specific lactate drop: 
First, cell-type specific expression of isoforms in the brain has been reported with MCT1 mainly 
expressed in astrocytes and oligodendrocytes and MCT2 in neurons (Pellerin et al., 2005). We assessed 
the influence of MCT isoforms on trans-acceleration with a numerical model and demonstrated an 
almost linear dependency of the pyruvate-induced trans-acceleration on intracellular baseline lactate 
levels for both MCT1 and MCT2 (Figure S2A-C). However, the relatively higher affinity of MCT2 than 
MCT1 for pyruvate in our model would predict stronger trans-acceleration of MCT2, i.e. in neurons 
(Figure S2A-C). Also, trans-acceleration can be induced in cultured neurons (Figure S2E) and astrocytes 
(Figure S2F), where baseline lactate levels depend on the experimental conditions. The differential 
MCT isoform expression and kinetics can therefore not explain the predominant trans-acceleration in 
astrocytes.  
Second, LDH diminishes lactate depletion caused by pyruvate uptake over time by transforming 
pyruvate into lactate. Intracellular lactate levels start to increase during pyruvate exposure if the rate 
of LDH-catalyzed conversion of pyruvate to lactate is high compared to lactate transport (Figure S2C) 
which may explain the delayed increase in lactate we observed following pyruvate infusion (Figure 5A). 
10 
 
However, the lower NADH/NAD+ ratio in neurons compared to astrocytes (Hung et al., 2011) implies 
weaker conversion of pyruvate to lactate and is therefore unlikely to mask pyruvate induced lactate 
depletion in neurons. 
Third, the brain vasculature is almost entirely covered by astrocytic endfeet (Mathiisen et al., 2010; 
McCaslin et al., 2011). Therefore, astrocytes are predominantly exposed to blood-borne pyruvate. The 
main transport limiting barrier for blood-borne pyruvate to enter brain tissue is MCT1 at the 
endothelial membranes and the fast diffusion within the tissue will expose all brain cells similarly 
(Halestrap, 2013; Miller and Oldendorf, 1986). Accordingly, we did not observe any temporal 
differences between astrocytic and neuronal lactate accumulation (Figure 2A and 3A). Additionally, 
buffering of lactate by Laconic is unlikely, because baseline lactate levels are higher (hundreds of µM 
instead of nM) and lactate transients are slower (multiple seconds instead of ms) than in the case of 
calcium dynamics, where buffering by the sensor is reported to be an issue (Grienberger and Konnerth, 
2012). Finally, increasing lactate levels in neurons lead to trans-acceleration and lactate efflux in 
neurons similarly as in astrocytes (Figure 5C-D).  
A higher resting state lactate level in astrocytes in comparison to neurons has significant implications 
for transcellular lactate exchange. Intracellular lactate accumulation driven by increased blood lactate 
and depletion during increased blood pyruvate is consistent with a facilitated transport of lactate via 
MCTs. The direction of a facilitated transport is determined by the concentration gradient, for which 
we found evidence to be from astrocytes to neurons as has been suggested by the ANLS (Pellerin and 
Magistretti, 1994) (Figure 6A). However, alternative lactate transport mechanisms have been 
suggested, such as via pannexins and connexins (Barros, 2013; Giaume et al., 2013) or an unknown 
potassium-dependent ion channel, which would allow active lactate transport even against a chemical 
concentration gradient during increased neuronal activity (Sotelo-Hitschfeld et al., 2015). 
In addition, astrocytic lactate could provide a small but fast energy reserve; cultured astrocytes have 
been shown to preferentially export glucose-derived lactate rather than lactate derived from glycogen 
(Sickmann et al., 2005). Glycogen may serve as a slower energy pool, as astrocytic glycogen-derived 
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lactate sustains neuronal function in rat optical nerve preparations for several minutes (Brown and 
Ransom, 2007). 
Our data provide important information about lactate concentrations of the different cellular 
compartments, which are fundamental for the role of lactate as an activity dependent signaling 
molecule (Mosienko et al., 2015). The transport of lactate from astrocytes to neurons has been shown 
to be necessary for the establishment of long-term memory (Suzuki et al., 2011) by inducing the 
expression of plasticity-related genes (Yang et al., 2014). Volatile halogenated anesthetics such as 
isoflurane are known to increase brain lactate levels (Boretius et al., 2013; Horn and Klein, 2010) and 
Fünfschilling and colleagues (Fünfschilling et al., 2012) reported a marked decrease in tissue lactate 
concentration in response to the discontinuation of isoflurane anesthesia, indicative of a substantial 
lactate exchange. In our study, we used injectable anesthetics to avoid elevated lactate levels, but our 
results can be used to interpret the direction of isoflurane-induced lactate exchange at the cellular 
level. It is important to note, however, that Laconic did not enable us to measure cellular or whole 
brain lactate transport or oxidation rates in vivo, as currently available pharmacological agents (such 
as the MCT blocker α-cyano-4-hydroxycinnamate) are neither fast (seconds) nor specific (limited side 
effects) enough.    Insert Figure 6 about here. 
In summary, the genetically encoded lactate sensor Laconic in combination with 2PLSM was 
successfully applied to investigate brain energy metabolism at the single cell level in vivo for the first 
time. We demonstrate that neurons and astrocytes readily take up blood-borne lactate. Our data 
suggest a significantly lower baseline lactate level in neurons in comparison to astrocytes. Our findings 
furthermore support the concept of compartmentalized lactate pools with a lactate flux from 
astrocytes to neurons.  
 
Experimental Procedures 
Viral constructs of the lactate sensor Laconic and the pyruvate sensor Pyronic  
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Genetically-encoded FRET sensors for lactate (‘Laconic’; San Martín et al., 2013), and pyruvate 
(‘Pyronic’; San Martín et al., 2014), were cloned into adeno-associated viral (AAV) plasmids for 
astrocyte and neuron specific expression. The astrocyte-specific construct included a minimal GFAP 
promoter (GfaABC1D, sGFAP; kindly provided by Dr. M. Brenner, Department of Neurobiology, 
University of Alabama) (Lee et al., 2008), a beta-globin intron, and a poly-adenylation signal. The 
neuronal construct included a human synapsin-1 (SYN) promoter, a Woodchuck Hepatitis Virus (WHP) 
Post-transcriptional Regulatory Element (WPRE) and a poly-adenylation signal (Glover et al., 2002; 
Kügler et al., 2001). The four different shuttle plasmids (pAAV-SYN-Laconic, pAAV-GFAP-Laconic, pAAV-
SYN-Pyronic, and pAAV-GFAP-Pyronic) were used to generate AAV serotype 6 (SYN constructs) or AAV 
serotype 9 (GFAP constructs) viral particles, by co-transfecting the shuttle plasmid with the pDP6 and 
pDF9 helper plasmids in HEK293-AAV cells (Agilent Technologies, Santa Clara, CA). Viral particles were 
isolated from the cell lysates, using iodixanol step gradients and HPLC purification on heparin-binding 
(AAV6) and ion exchange (AAV9) columns. The number of viral genomic copies (VG) was measured by 
TaqMan real-time PCR, with primers amplifying specific sequences in the human beta-globin intron or 
WPRE element. 
Animals 
All experimental procedures were approved by the local veterinary authorities in Zurich and 
conformed to the guidelines of the Swiss Animal Protection Law, Veterinary Office, Canton of Zurich 
(Act of Animal Protection 16 December 2005 and Animal Protection Ordinance 23 April 2008). Surgery 
was performed in female wild type mice (C57BL/6J; Charles River) of 8 to 10 weeks of age (20 to 25 
gram bodyweight). The mice had free access to water and food and an inverted 12-hour light/dark 
cycle. 
 Anesthesia 
The animals were anesthetized with a mixture of fentanyl (0.05 mg per kg bodyweight; Sintenyl, 
Sintetica, Switzerland), midazolam (5 mg per kg bodyweight; Dormicum, Roche, Switzerland) and 
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medetomidine (0.5 mg per kg bodyweight; Domitor, Orion Pharma, Finland) intraperitoneally and 
anesthesia was maintained with midazolam (5 mg per kg bodyweight) subcutaneously after 50 
minutes. To prevent hypoxaemia, a face mask provided 300 mL/min of 100% oxygen. Core 
temperature was kept constant at 37°C using a homeothermic blanket heating system during all 
surgical and experimental procedures (Harvard Apparatus, Holliston, MA, USA). The head was fixed in 
a stereotaxic apparatus and the eyes were kept wet with ointment (vitamin A eye cream; Bausch & 
Lomb, Switzerland).  
Virus injection 
 A 4x4 mm craniotomy was performed above the somatosensory cortex using a dental drill (Bien-Air, 
Bienne, Switzerland) and solutions containing virus vector were injected into the primary 
somatosensory cortex at a close distance to achieve neighboring, but non-overlapping, sensor protein 
expression: 75 nL of AAV9-GFAP-Laconic (titer 3.1E12 VG/mL); 150 nL of AAV6-SYN-Laconic (titer 
1.02E13 VG/mL) (San Martín et al., 2013); 75 nL of AAV9-GFAP-Pyronic (titer 1.6E12 VG/mL); 150 nL of 
AAV6-SYN-Pyronic (titer 1.15E12 VG/mL) (San Martín et al., 2014). Large vessels were avoided to 
prevent bleeding and the absorption of light by hemoglobin during imaging. A square cover slip (3x3 
mm, UQG Optics Ltd, UK) was placed on the exposed dura mater and fixed to the skull with dental 
cement, according to published protocols (Holtmaat et al., 2009). 
 Head-post implantation  
A bonding agent (Gluma Comfort Bond; Heraeus Kulzer, Hanau, Germany) was applied to the cleaned 
skull and polymerized with a handheld blue light source (600 mW/cm2; Demetron LC, Switzerland). A 
custom-made aluminium head post was connected with dental cement (EvoFlow; Ivoclar Vivadent AG, 
Liechtenstein) to the bonding agent for later reproducible animal fixation in the microscopic setup. The 
skin lesion was treated with antibiotic ointment (Neomycin, Cicatrex; Janssen-Cilag AG, Switzerland) 
and closed with acrylic glue (Histoacryl, B. Braun, Germany). After surgery the animals were kept warm 
and provided with analgesics (metamizole 0.2 mg/g bodyweight; Sintetica, Switzerland) and an 
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antibiotic was added to the drinking water (enrofloxacin, 200 mg/l drinking water; Baytril, Bayer, 
Germany). Sensor protein expression was checked using a fluorescence stereomicroscope (Leica MZ16 
FA) two to three weeks after virus injection and prior to imaging. 
Intracellular lactate measurements 
The mice were imaged using a custom-built two-photon laser scanning microscope (2PLSM) with a 
tunable pulsed laser (MaiTai eHP DS system, Spectra-Physics, CA, USA) at 870 nm wavelength and 
equipped with a 20x water immersion objective (W-Plan-Apochromat 20x/1.0 differential interference 
contrast, Zeiss, Germany). During measurements the animals were head-fixed and kept under the 
anesthesia described above. The galvo-mirrors and a motorized objective were used to cycle through 
two to four individual fields of view. Unidirectional frame scans at 0.1 Hz and 512x512 pixels resolution 
were acquired with ScanImage (r3.8.1; Janelia Research Campus; Pologruto et al., 2003)). Lactate 
concentration in cultured cells were measured with the use of Laconic as previously described (Sotelo-
Hitschfeld et al., 2015). 
Extracellular lactate measurements 
Extracellular lactate measurements were performed with a commercially available recording system 
(Pinnacle Inc., Lawrence, KS, USA). Mice were fixed in a stereotactic frame under anesthesia (isoflurane 
1.5%; Abbott, North Chicago, IL, USA), the skull was opened with a dental drill, and a guide cannula 
(Part 7032, Pinnacle Technology, Lawrence, KS, USA) was implanted into the primary somatosensory 
cortex (from bregma: A/P +1.41, M/L -2.8, D/V -1.0) and fixed with dental cement to an anchor screw 
(Part 8209, Pinnacle Technology, Lawrence, KS, USA). After a recovery period of two weeks, the pre-
calibrated lactate biosensor was inserted into the guide cannula (Naylor et al., 2012). A tail vein 
catheter was inserted for saline, lactate and pyruvate infusions. Recording started after one hour of 
signal stabilization. 
 Blood lactate level measurements 
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The femoral artery was exposed and cannulated with fine bore polyethylene tubing (0.28 mm ID, 0.61 
mm OD, Portex, Smith medical, UK) to measure blood lactate level. Blood drops were removed from 
the cannula and every fourth drop was used for an enzymatic lactate assay (Lactate Pro 2, Arkray, 
Japan). After each blood sample analysis, the tubing was rinsed with heparinized (50 IU/ml) 0.9% saline 
solution. 
 Intervention protocols 
For intravenous interventions, a 30 Gauge needle was connected to fine bore polyethylene tubing 
(0.28 mm ID, 0.61 mm OD, Portex, Smith medical, UK), filled with 0.9% saline solution and inserted into 
one of the tail veins. Before imaging, the tubing was connected via an X connector (model SC25, 
Instech, USA) to peristaltic pumps (Reglo digital ISM 831, Ismatec SA, Germany), which were operated 
via custom written Matlab codes. A 500 mM solution of sodium chloride (S7653, Sigma-Aldrich, MO, 
USA), sodium L-lactate (L7022, Sigma, MO, USA) or sodium pyruvate (P2256, Sigma-Aldrich, MO, USA) 
at 4 mmol per kg bodyweight was injected during 3 minutes.  
 Immunohistochemistry 
Four mice expressing astrocytic and neuronal Laconic sensors and one mouse intraperitoneally 
injected with 2 mg per kg bodyweight lipopolysaccharides (Fontana et al., 1981) were anesthetized 
with pentobarbital (Nembutal, >50 mg/kg) intraperitoneally and transcardially perfused with 2% 
paraformaldehyde to assess immunohistochemical alterations. Brains were post-fixed in 4% 
paraformaldehyde, rinsed with phosphate-buffered saline (PBS), and cryoprotected with 30 % sucrose 
in PBS. The frozen brains were then cut into 40 µm sections with a sliding microtome and fluorescent 
regions were identified with a fluorescence stereomicroscope (Leica MZ16 FA; Leica Microsystems, 
Germany). Free-floating sections were incubated with rabbit anti-Glial fibrillary acidic protein (GFAP) 
antibody (Z0334; DakoCytomation, DK), rabbit anti-fibrinogen antibody (A0080; DakoCytomation, DK) 
or rat anti-CD68 antibody (MCA1957GA; AbD Serotec) and stained with red-fluorescent secondary 
antibody (goat anti-rabbit and goat anti-rat Cy3; Jackson Immuno Research Laboratories Inc.). Images 
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of the sections were collected with a laser-scanning confocal microscope (LSM510-Meta; Zeiss, 
Germany).  
Cell culture experiments 
All animal procedures for the cell culture experiments were approved by the Institutional Animal Care 
and Use Committee of the Centro de Estudios Científicos. Mixed cortical cultures of neuronal and glial 
cells were prepared from 1-3 day-old neonates (C57BL/6J) as detailed previously (Bittner, 2010). For 
Laconic sensor expression, cultures were exposed to 5 x 106 PFU of Ad Laconic and studied after 48 h 
(culture day 8-10). The co-culture cells were imaged with an upright Olympus FV1000 confocal 
microscope and a 440 nm solid-state laser as detailed previously (Sotelo-Hitschfeld et al., 2015). 
Masked ratio images were generated from background-subtracted images using ImageJ software. 
Data analysis and statistics 
Astrocytic domains and neuronal cytoplasm of individual cells of cortical layers L2/3 (150-250 µm 
below the dura) were outlined using ImageJ (1.46r; National Institutes of Health, USA). The mTFP 
channel (with bandpass filter 475/64; Semrock, USA) was divided by the Venus channel (with bandpass 
filter 542/50; Semrock, USA) and the ratio was normalized to the corresponding baseline or as 
indicated in the figure legend using Matlab (MathWorks, USA). Time acquisition curves are filtered 
with a moving average of five frames and indicated as mean ± standard deviation. Effects in multiple 
animals were compared using t-tests in R (R Core Team, 2014). P values < 0.05 were taken as 
significance limit. 
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Figure Legends 
Figure 1. Expression of Laconic and Pyronic in vivo. (A top) 3D-Structure of the lactate sensor Laconic, 
which was excited with a pulsed laser (870 nm). Emission was collected for mTFP (450-475 nm) and for 
Venus (535-550 nm). (A bottom) The fluorescence (480 nm excitation, 505-565 nm emission, green) of 
four individual sensors was collected through a chronic cranial window preparation of the primary 
somatosensory cortex of a C57BL/6 mice, scale bar: 1 mm. (B top) Serotype 6 adeno-associated viral 
vector (AAV6) with a synapsin promoter was used for neuronal expression, and serotype 9 vector 
(AAV9) with a sGFAP promoter for astrocytic expression. (B bottom) 2PLSM at 150 to 250 µm below 
the dura shows cell-type specific cytoplasmic sensor expression with nuclear exclusion (arrow heads), 
vascular end feet (arrows) and cellular processes (stars); scale bars: 50 µm. (C) The in vitro calibration 
curve of Laconic at 37°C shows substrate binding kinetics of lactate but no pH sensitivity. See also 
Figure S1A to E. 
 
Figure 2. Laconic sensor functions in vivo. (A) Laconic signals increased both in astrocytes and neurons 
depending on the intravenously injected lactate dosage (Lac; 500 mM L-lactate solution; 0.5, 1 and 2 
mmol per kg bodyweight; 0 mmol lactate was performed with 2 mmol per kg bodyweight of 500 mM 
sodium chloride solution). The standard deviations of cells in a single experiment (left) and of multiple 
independent experiments (right) are indicated (from 0 to 2 mmol/kg; normalization to individual 
baseline). See also Figure S1F, S1G, S3A and S3B. (B) Similarly, Laconic expressed in cultured astrocytes 
and neurons showed dose dependent signal increases. Data are normalized to pyruvate induced 
lactate depletion (see Figure S2D and S2E). Astrocytes but not neurons maintain sizable intracellular 
lactate levels even in a zero glucose and lactate medium, resulting in relatively low Laconic signal 
increases. 
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Figure 3. An intravenous injection of lactate increases Laconic signals more in neurons than in 
astrocytes. (A) Intravenous lactate infusions (4 mmol per kg bodyweight in 3 minutes, 500 mM 
solution) increased neuronal (5.7 ± 1.3%) more than astrocytic Laconic signal (4.3 ± 1.3%) in 
simultaneous recordings in one experiment (left) and over multiple recordings (right, normalization to 
individual baseline, mean on peak amplitudes, * = p < 0.05). See also Figure S3C. (B) The same lactate 
infusion protocol increased extracellular lactate (N = 6 animals, 0.27 ± 0.08 mM). (C) Blood lactate 
concentrations rose from 0.81 ± 0.26 mM to 17 ± 5.7 mM (N = 7 experiments). Data are represented 
as mean ± SD. 
 
Figure 4. Baseline lactate levels in astrocytes and neurons can be compared by saturating Laconic. 
(A) Astrocytic and neuronal Laconic and Pyronic were simultaneously recorded during an intravenous 
infusion of ammonium chloride (4 mmol per kg bodyweight in 15 minutes, 500 mM solution) mixed 
with lactate (8 mmol per kg bodyweight in 15 minutes, 1 M solution), followed by a faster lactate 
injection (4 mmol per kg bodyweight in 3 minutes, 500 mM solution). Pyronic signals decreased during 
the ammonium chloride-lactate mix. In eight independent experiments, normalization to the 
saturation level of Laconic revealed lower baseline levels in neurons than in astrocytes (0.901 ± 0.024 
vs. 0.931 ± 0.020, normalization to the three minutes after ammonium chloride stop, mean of baseline 
minima, * = p < 0.05). (B) Using the same infusion protocol, changes in extracellular lactate 
concentrations were measured in five trials. Extracellular lactate increased until the end of the infusion 
protocol by 0.87 ± 0.29 mM. Data are represented as mean ± SD. See also Figure S1H and S1I. 
 
Figure 5. An intravenous injection of pyruvate decreases Laconic signals more in astrocytes than in 
neurons. (A) Intravenous pyruvate infusions (4 mmol per kg bodyweight in 3 minutes, 500 mM 
solution) decreased Laconic signal in astrocytes more than in neurons, while inducing only minor 
changes in Pyronic signal, as observed during simultaneous recordings in one experiment (left, 
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normalization to individual baseline). Similar effects were observed over multiple recordings (right, 
normalization to individual baseline, maximum decrease of astrocytes was 4.7 ± 1.5 and of neurons 
0.6 ± 0.9 %, * = p < 0.05). (B) The same pyruvate infusion protocol increased extracellular lactate (N = 
6 animals, 0.084 ± 0.02 mM). (C) The Laconic saturation protocol (see figure 4) was followed by a 
pyruvate infusion, which induced a decrease of astrocytic and neuronal Laconic signal and an increase 
in Pyronic signal. Normalization to three minutes after cessation of ammonium chloride infusion. (D) 
In some trials repetitive pyruvate infusions increased Laconic signal in neurons, possibly due to 
conversion of pyruvate to lactate. With this artificially increased neuronal lactate levels, a pyruvate 
infusion (2 mmol per kg bodyweight in 1 minute, 500 mM solution) induced trans-acceleration also in 
neurons. Normalization to last minute of trace. (E) Trans-acceleration occurs at monocarboxylate 
transporters (MCT), because the substrate binding site of MCTs switches at a higher rate to the other 
side of the membrane when a substrate is bound (MCT – S; k2) than without a substrate bound (MCT; 
k1). Therefore, any substrate of MCT on one side of the membrane increases the rate of transport of 
another substrate in the opposite direction. Data are represented as mean ± SD. See also Figure S2. 
 
Figure 6. Model of lactate compartmentation. (A) Astrocytes accumulate lactate, which is transported 
along a concentration gradient via monocarboxylate transporters (MCT) to be consumed by neurons. 
Physiological (phys.) and experimentally increased (exp.) blood lactate levels are indicated. (B) Under 
artificially increased blood pyruvate levels, pyruvate enters brain cells from extracellular space via 
MCTs, forcing the extrusion of lactate. Pyruvate entry and concurrent lactate exit via MCTs requires 
relatively high intracellular lactate levels.  
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Supplemental Text & Figures
Figure S1. Laconic immunohistochemistry and specificity. Related to Figure 1, 3 and 4. 
(A) Neuronal (left) and astrocytic (middle) Laconic fluorescence acquired post mortem using 
confocal microscopy. Cortical area without virus injection (right). Scale bar: 200 µm. (B) Both, 
astrocytic (blue frame) and neuronal (red frame) Laconic expressing tissue showed sparsely 
GFAP-positive astrocytes (arrows) without an increase compared to contralateral (gray frame) 
layer 2/3 cortex (image sections correspond to frame selections in panel A). The same GFAP 
staining was positive in mice injected with lipopolysaccharide (LPS, yellow frame), which is 
known to induce cortical inflammation (Fontana et al., 1981). (C) Fibrinogen staining was 
restricted to vessels (arrows) without any sign of blood brain barrier leakage as in LPS treated 
mice. (D) Staining for CD68 did not indicate an increased number or reactivity of microglia as 
with LPS treatment (arrows). Scale bars in figures B-D: 50 µm. (E) The in vitro calibration curve 
of Laconic shows the substrate binding kinetics of lactate at 25° celsius (San Martín et al., 
2013). (F) Increasing the output laser power from 4 to 59 mW (measured under the objective) 
increased the fluorescence intensity in the Venus and mTFP channel, but did not affect ratio 
values at laser intensities used in this study (20 to 40 mW, grey bar). In the rightmost subpanel, 
laser power values measured in a set of experiments with pyruvate infusions are indicated. (G) 
The intravenous injection of sodium chloride (4 mmol per kg bodyweight in three minutes, 500 
mM solution) did not show different signal changes in astrocytes and neurons (n.s. = p > 0.05). 
(H) Ammonium chloride (NH4Cl) infusions over four minutes (2.5 mmol/kg bodyweight) 
increased Laconic signals in neurons and astrocytes (7.3 ± 1.3% vs. 7.4 ± 1.6%, respectively, 
normalization to baseline, mean of peak amplitudes, n.s. = p > 0.05). (I) Repetitive infusions 
of pyruvate (2 mmol per kg bodyweight in 1.5 minutes, 500 mM solution) were followed by the 
Laconic saturation protocol (ammonium chloride 4 mmol per kg bodyweight 500 mM solution 
mixed with lactate 8 mmol per kg bodyweight 1 M solution in 15 minutes). Normalization to the 
sensor’s saturation point demonstrates the convergence of astrocytic and neuronal Laconic 
under pyruvate induced trans-acceleration (upper traces). The simultaneous measurement of 
the pyruvate sensor Pyronic demonstrates the specificity of Laconic to lactate (lower traces). 
Data are represented as mean ± SD. 
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Figure S2. In silico modeling of trans-acceleration and in vitro controls. Related to 
Figure 2 and 5. 
Lactate and pyruvate are transported in and out of cells through monocarboxylate transporters 
(MCTs). Competition between the two substrates for the shared binding site in the transporter 
and the fact that the binding site trans-locates more efficiently when complexed with a 
substrate leads to trans-acceleration (also known as accelerated exchange (Garcia et al., 
1994), that is the enhancement of transport of a substrate located at the opposite side of the 
membrane. Trans-acceleration can be explained with the following kinetic model: (A) 
Simulation results of intracellular lactate and pyruvate concentrations using kinetic parameters 
of the MCT 2 (4 µM; symmetrically distributed; pH 7.4; Koff lactate 7.6 x 106 s-1 and Koff pyruvate 
7.6 x 105 s-1) during an extracellular 2 mM pyruvate challenge. Each line represents a different 
steady state lactate concentration from 0 to 1 mM at baseline. The rate of LDH is set to 10-4 s-
1 and the reverse reaction 20 times lower, putting the ratio lactate/pyruvate to 20. (B) The same 
model as before but with the kinetic parameters of MCT 1 (20 µM; symmetrically distributed; 
pH 7.4; Koff lactate 7.6 x 107 s-1 and Koff pyruvate 7.6 x 106 s-1). (C) The contribution of LDH 
activity on pyruvate induced transients in the MCT 2 model is demonstrated for a wide range 
of LDH rates. (D) In the two MCT models, the amplitude of lactate depletion after 20 s depends 
linearly on the baseline lactate level and is larger with MCT 2 than MCT 1 (top). Pyruvate 
accumulates more in the MCT1 model (bottom). (E) Cultured neurons expressing Laconic 
showed pyruvate dose dependent lactate depletion (cells in a Krebs Ringer Hepes Bicarbonate 
buffer with 2 mM glucose and 1 mM lactate). (F) Cultured astrocytes in the same buffer solution 
showed similar Laconic transients. Data are represented as mean ± SD. (G) Under 
physiological conditions pyruvate concentrations are too low to compete with lactate at MCTs 
(left). After a rise in extracellular pyruvate (right part), the transporters bind pyruvate, which 
results in a reduced binding site availability for lactate and a reduction of lactate influx. Then 
the binding site trans-locates from outward-facing to inward-facing configuration. If there is 
lactate within the cell, the increased number of inward-facing sites subsequently causes an 
increased lactate efflux. The combination of reduced lactate influx and increased lactate efflux 
results in a drop of intracellular lactate concentration. This increase of lactate flux by pyruvate 
in this example is analogous to the extrusion of calcium by sodium in the Na+-Ca2+ exchanger.  
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Figure S3. Characterization of intracellular and extracellular lactate measurements. 
Related to Figure 2, 3, 4 and 5.  
(A) and (B) demonstrate that the Laconic FRET ratio is independent from sensor expression 
levels. (A) A sample measurement from baseline (frame 10) from each cell imaged in this study 
was taken and the sum of the two channels was plotted against their ratio. (B) The same plot 
is given for cultured astrocytes. (C) Demonstration of reproducibility over different imaging 
sessions. Repetitive lactate infusions in a single mouse on day 1, 8 and 13 increased Laconic 
signals in variable populations of layer 2/3 neocortical neurons and astrocytes. (D) Comparison 
of the in vitro pre- and post- calibration values from the extracellular lactate biosensors used 
in vivo demonstrates that the sensitivity of the sensor was preserved within an experiment. 
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